Page last updated: 2024-10-24

positive regulation of smooth muscle cell apoptotic process

Definition

Target type: biologicalprocess

Any process that activates or increases the frequency, rate, or extent of smooth muscle cell apoptotic process. [GOC:BHF, GOC:mtg_apoptosis, GOC:rl]

Positive regulation of smooth muscle cell apoptotic process is a complex biological process involving a series of molecular events that ultimately lead to the programmed death of smooth muscle cells. This process is tightly regulated and is essential for maintaining tissue homeostasis, preventing excessive cell proliferation, and promoting tissue remodeling. The process is initiated by a variety of stimuli, including growth factors, hormones, and cytotoxic agents. These stimuli activate signaling pathways that converge on the mitochondria, which release pro-apoptotic factors, including cytochrome c. Cytochrome c activates caspase-9, which in turn activates downstream caspases, including caspase-3. Caspase-3 is the main executioner caspase and cleaves various cellular proteins, leading to the dismantling of the cell. The process also involves the activation of other pro-apoptotic proteins, such as BAX and BAK, which promote the release of cytochrome c from the mitochondria. The process is negatively regulated by anti-apoptotic proteins, such as Bcl-2 and Bcl-xL, which inhibit the activation of caspase-9 and the release of cytochrome c. In addition, the process is regulated by various transcription factors, including p53, which can induce the expression of pro-apoptotic genes. Dysregulation of the process is implicated in various diseases, including atherosclerosis, pulmonary hypertension, and fibrosis.'
"

Proteins (1)

ProteinDefinitionTaxonomy
Forkhead box protein O1A forkhead box protein O1 that is encoded in the genome of human. [PRO:PD]Homo sapiens (human)

Compounds (2)

CompoundDefinitionClassesRoles
psammaplysene apsammaplysene A: dimeric bromotyrosine alkaloid; specific inhibitor of FOXO1a nuclear export; structure in first source
as 18428565-amino-7-(cyclohexylamino)-1-ethyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid: inhibits Foxo1 transactivation; inhibits mRNA levels of glucose-6-phosphatase and phosphoenolpyruvate carboxykinase; structure in first source

AS1842856 : A quinolone that is 4-quinolone substituted at positions 1, 3, 5, 6 and 7 by ethyl, carboxy, amino, fluorine, and cyclohexylamino groups, respectively. It can directly bind to and block the transcription activity of the active forkhead box protein O1 (Foxo1), but not the Ser256-phosphorylated form. It induces cell death and growth arrest in Burkitt lymphoma cell lines at low concentrations.
organofluorine compound;
primary amino compound;
quinolinemonocarboxylic acid;
quinolone;
secondary amino compound;
tertiary amino compound
anti-obesity agent;
antineoplastic agent;
apoptosis inducer;
autophagy inhibitor;
forkhead box protein O1 inhibitor;
hypoglycemic agent